Opus Capital Group’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Opus Capital Group’s Portfolio NWBO Stock Details NWBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12K	Hold	60,150	–	–	﹤0.01%	136
2025 Q4	$14K	Hold	60,150	–	–	﹤0.01%	134
2025 Q3	$14K	Hold	60,150	–	–	﹤0.01%	134
2025 Q2	$14K	Hold	60,150	–	–	﹤0.01%	123
2025 Q1	$14K	Hold	60,150	–	–	﹤0.01%	121
2024 Q4	$17K	Hold	60,150	–	–	﹤0.01%	116
2024 Q3	$19K	Hold	60,150	–	–	﹤0.01%	120
2024 Q2	$26K	Hold	60,150	–	–	﹤0.01%	117
2024 Q1	$31K	Hold	60,150	–	–	﹤0.01%	121
2023 Q4	$42K	Hold	60,150	–	–	0.01%	118
2023 Q3	$55K	Hold	60,150	–	–	0.01%	112
2023 Q2	$34K	Hold	60,150	–	–	0.01%	120
2023 Q1	$38K	Hold	60,150	–	–	0.01%	118
2022 Q4	$47K	Buy	60,150 +5,000	+9%	+$3.91K	0.01%	114
2022 Q3	$39K	Hold	55,150	–	–	0.01%	106
2022 Q2	$35K	Buy	55,150 +10,000	+22%	+$6.35K	0.01%	110
2022 Q1	$31K	Hold	45,150	–	–	0.01%	109
2021 Q4	$32K	Hold	45,150	–	–	0.01%	104
2021 Q3	$58K	Hold	45,150	–	–	0.01%	98
2021 Q2	$66K	Buy	45,150 +650	+1%	+$950	0.02%	123
2021 Q1	$66K	Hold	44,500	–	–	0.02%	125
2020 Q4	$68K	Buy	44,500 +19,500	+78%	+$29.8K	0.02%	126
2020 Q3	$19K	Buy	25,000 +15,000	+150%	+$11.4K	0.01%	117
2020 Q2	$3K	Hold	10,000	–	–	﹤0.01%	113
2020 Q1	$2K	Hold	10,000	–	–	﹤0.01%	104
2019 Q4	$2K	Hold	10,000	–	–	﹤0.01%	161
2019 Q3	$2K	Hold	10,000	–	–	﹤0.01%	145
2019 Q2	$3K	Buy	+10,000	New	+$3K	﹤0.01%	166

Other funds holding NWBO

KFA

Kelleher Financial Advisors New York $395M AUM 12.89% 1-Year Est. Return

VWA

VSM Wealth Advisory Hunt Valley, Maryland $376M AUM 21.56% 1-Year Est. Return

EFG

Ethos Financial Group King Of Prussia, Pennsylvania $1.37B AUM 19.43% 1-Year Est. Return

WJWM

Williams Jones Wealth Management New York $8.14B AUM 19.32% 1-Year Est. Return

McIlrath & Eck Arlington, Washington $1.35B AUM 15.78% 1-Year Est. Return

Opus Capital Group's NWBO Position: Q1 2026 in Review

Opus Capital Group held its Northwest Biotherapeutics, Inc. Common stock (NWBO) position steady in Q1 2026 at 60,150 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #136.

Opus Capital Group first reported a position in NWBO in Q2 2019 and has held it in 28 quarters since. The position peaked at $68K in Q4 2020. 8 funds tracked by Wall St. Rank hold NWBO as of Q1 2026.

Opus Capital Group held 60,150 shares of Northwest Biotherapeutics, Inc. Common stock worth $12K as of Q1 2026.
Opus Capital Group left its Northwest Biotherapeutics, Inc. Common stock share count unchanged in Q1 2026.
Northwest Biotherapeutics, Inc. Common stock made up ﹤0.01% of Opus Capital Group's portfolio in Q1 2026, its #136 holding.
Opus Capital Group first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q2 2019 and has held it in 28 quarters since.
Opus Capital Group's Northwest Biotherapeutics, Inc. Common stock position peaked at $68K in Q4 2020.
8 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q1 2026.

Based on Opus Capital Group's 13F filing for Q1 2026, filed 30 Apr 2026.